drug
PIMAVANSERIN
updated 3mo agoby $MSN EMERSON RADIO CORP
community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying PIMAVANSERIN
- phase4Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
- phase2Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
- phase2Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.
- phase3A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis
- phase3Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder
- phase3Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder
- phase3Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia
- phase3Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 28m ago
Found something off?
comments(0)
5-min edit window · permanent after that